Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.13 USD | -0.13% | -0.68% | +7.87% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Transcripts